Biotalys NV (EBR:BTLS)

Market Cap	118.03M
Revenue (ttm)	n/a
Net Income (ttm)	-13.19M
Shares Out	37.47M
EPS (ttm)	-0.40
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,467
Average Volume	16,520
Open	3.150
Previous Close	3.150
Day's Range	3.140 - 3.180
52-Week Range	2.510 - 3.750
Beta	0.89
RSI	47.37
Earnings Date	Aug 20, 2025

About Biotalys NV

Biotalys NV, an agricultural technology company, discovers and develops novel biological products in Belgium and internationally. The company offers biofungicides and bioinsecticides. It also provides the AGROBODY Foundry technology platform, which generates protein-based crop protection products. In addition, the company develops EVOCA 1st generation, EVOCA Next generation, and BIOFUN-6 targeting botrytis, powdery mildew, and anthracnose in fruits and vegetables; BIOFUN-7 targeting leafspot disease in cowpeas and other legumes; BIOFUN-4 target...

• Industry: Agricultural Inputs
• Sector: Materials
• Founded: 2013
• Employees: 63
• Stock Exchange: Euronext Brussels
• Ticker Symbol: BTLS